FY27-28 Pediatric Flu Vaccines
CDC · CDC OFFICE OF ACQUISITION SERVICES
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75D30126R73518 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA �93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of e… (show all)
ffective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA �93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. � 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
Who won similar work
13 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| GLAXOSMITHKLINE, LLC | 3 | $1.7B | Mar 27, 2026 |
| SEQIRUS USA INC | 2 | $663.9M | Dec 31, 2024 |
| SANOFI PASTEUR INC. | 2 | $233.3M | Dec 31, 2024 |
| ASTRAZENECA PHARMACEUTICALS LP | 2 | $61.0M | Dec 31, 2024 |
| MERCK SHARP & DOHME LLC · $MRK | 1 | $4.5B | Mar 27, 2026 |
| PFIZER INC · $PFE | 1 | $2.1B | Mar 27, 2026 |
| SANOFI VACCINES US INC. | 1 | $1.9B | Mar 27, 2026 |
| BAVARIAN NORDIC, INC. | 1 | $7.0M | Mar 27, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Mar 27, 2026BAVARIAN NORDIC, INC.$7.0MVaccines for Children (VFC) FY26
- Mar 27, 2026GLAXOSMITHKLINE, LLC$1.5BVaccines for Children (VFC) FY26
- Mar 27, 2026SANOFI VACCINES US INC.$1.9BVaccines for Children (VFC) FY26
- Mar 27, 2026PFIZER INC$2.1BVaccines for Children (VFC) FY26
- Mar 27, 2026MERCK SHARP & DOHME LLC$4.5BVaccines for Children (VFC) FY26
- Dec 31, 2024SANOFI PASTEUR INC.$70.2MAdult Flu Vaccines 2025-2026
- Dec 31, 2024SEQIRUS USA INC$253.3MAdult Flu Vaccines 2025-2026
- Dec 31, 2024SEQIRUS USA INC$410.6MPediatric Flu Vaccine � 2025-2026
- Dec 31, 2024SANOFI PASTEUR INC.$163.1MPediatric Flu Vaccine � 2025-2026
- Dec 31, 2024ASTRAZENECA PHARMACEUTICALS LP$9.1MAdult Flu Vaccines 2025-2026
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (9 filings)
- 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
- $243K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 6 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 2 of the past winners are listed companies
- 3 insider buys and 8 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.